SCHEMBL8779044

SCHEMBL8779044

O=C1c2cccc(OCc3ccccc3)c2CCC12CCCC2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.52
LMNA P02545 4/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
NCOA3 Q9Y6Q9 1/20 0.51
MRGPRX4 Q96LA9 2/20 0.48
ALDH1A1 P00352 1/20 0.46
CRBN Q96SW2 1/20 0.45
IKZF3 Q9UKT9 1/20 0.45
POLB P06746 1/20 0.44
RECQL P46063 1/20 0.44
RXRB P28702 5/20 0.43
RXRA P19793 4/20 0.43
RXRG P48443 3/20 0.43
BRD4 O60885 2/20 0.43
CREBBP Q92793 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
MAPT P10636 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8779163 0.85 HTT (0.46) HTTLMNASMN1; SMN2L3MBTL1NCOA3
SCHEMBL8778923 0.80 DRD2 (0.41) HTTLMNASMN1; SMN2L3MBTL1NCOA3
SCHEMBL5101144 0.77 MRGPRX4 (0.74) HTTLMNASMN1; SMN2L3MBTL1NCOA3
SCHEMBL31318410 0.77 MRGPRX4 (0.74) HTTLMNASMN1; SMN2L3MBTL1NCOA3
SCHEMBL3629080 0.76 MRGPRX4 (0.62) HTTLMNASMN1; SMN2L3MBTL1NCOA3
SCHEMBL25713331 0.75 ABCB1 (0.43) HTTCRBNIKZF3POLBRECQL
SCHEMBL8778993 0.73 MAOB (0.63) SMN1; SMN2ALDH1A1DRD2HTR2AHTR2C
SCHEMBL8779017 0.73 MAOB (0.63) SMN1; SMN2ALDH1A1
SCHEMBL30112286 0.73 HTT (0.56) HTTLMNASMN1; SMN2L3MBTL1NCOA3
SCHEMBL34466766 0.73 MAPT (0.45) L3MBTL1MRGPRX4RXRBRXRARXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606661-B1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists HOFFMANN LA ROCHE (CH) 1997-03-12 EP disclosed
US-5385947-A For prevention of nerve damage due to reduction of blood or oxygen supplies HOFFMANN-LA ROCHE INC. (US) 1995-01-31 US disclosed
EP-0606661-A1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists F. HOFFMANN-LA ROCHE AG (CH) 1994-07-20 EP disclosed